Annual Net Income
-$366.29 M
-$96.56 M-35.80%
31 December 2023
Summary:
Ionis Pharmaceuticals annual net profit is currently -$366.29 million, with the most recent change of -$96.56 million (-35.80%) on 31 December 2023. During the last 3 years, it has risen by +$77.98 million (+17.55%). IONS annual net income is now -231.69% below its all-time high of $278.14 million, reached on 31 December 2019.IONS Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$140.48 M
-$74.22 M-112.00%
30 September 2024
Summary:
Ionis Pharmaceuticals quarterly net profit is currently -$140.48 million, with the most recent change of -$74.22 million (-112.00%) on 30 September 2024. Over the past year, it has increased by +$6.93 million (+4.70%). IONS quarterly net income is now -143.89% below its all-time high of $320.08 million, reached on 31 December 2018.IONS Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$358.81 M
+$6.93 M+1.89%
30 September 2024
Summary:
Ionis Pharmaceuticals TTM net profit is currently -$358.81 million, with the most recent change of +$6.93 million (+1.89%) on 30 September 2024. Over the past year, it has increased by +$50.64 million (+12.37%). IONS TTM net income is now -183.48% below its all-time high of $429.81 million, reached on 30 September 2019.IONS TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IONS Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -35.8% | +4.7% | +12.4% |
| 3 y3 years | +17.6% | -70.3% | +41.0% |
| 5 y5 years | -233.8% | -636.9% | -183.5% |
IONS Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -1180.8% | +17.6% | -162.5% | +4.7% | -5001.1% | +41.0% |
| 5 y | 5 years | -231.7% | +17.6% | -162.5% | +60.4% | -183.5% | +41.0% |
| alltime | all time | -231.7% | +17.6% | -143.9% | +60.4% | -183.5% | +41.0% |
Ionis Pharmaceuticals Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$140.48 M(+112.0%) | -$358.81 M(-1.9%) |
| June 2024 | - | -$66.27 M(-53.6%) | -$365.74 M(-4.9%) |
| Mar 2024 | - | -$142.80 M(+1441.6%) | -$384.77 M(+5.0%) |
| Dec 2023 | -$366.29 M(+35.8%) | -$9.26 M(-93.7%) | -$366.29 M(-10.5%) |
| Sept 2023 | - | -$147.41 M(+72.8%) | -$409.45 M(+32.5%) |
| June 2023 | - | -$85.29 M(-31.4%) | -$309.04 M(-6.0%) |
| Mar 2023 | - | -$124.32 M(+137.1%) | -$328.88 M(+21.9%) |
| Dec 2022 | -$269.72 M(+843.2%) | -$52.43 M(+11.6%) | -$269.72 M(-3784.2%) |
| Sept 2022 | - | -$46.99 M(-55.3%) | $7.32 M(-126.0%) |
| June 2022 | - | -$105.14 M(+61.3%) | -$28.15 M(+623.2%) |
| Mar 2022 | - | -$65.17 M(-129.0%) | -$3.89 M(-86.4%) |
| Dec 2021 | -$28.60 M(-93.6%) | $224.61 M(-372.4%) | -$28.60 M(-95.3%) |
| Sept 2021 | - | -$82.47 M(+2.0%) | -$607.74 M(+10.6%) |
| June 2021 | - | -$80.88 M(-10.0%) | -$549.74 M(+11.2%) |
| Mar 2021 | - | -$89.87 M(-74.7%) | -$494.50 M(+11.3%) |
| Dec 2020 | -$444.26 M(-259.7%) | -$354.53 M(+1349.0%) | -$444.26 M(-664.6%) |
| Sept 2020 | - | -$24.47 M(-4.6%) | $78.68 M(-39.2%) |
| June 2020 | - | -$25.64 M(-35.3%) | $129.31 M(-16.1%) |
| Mar 2020 | - | -$39.63 M(-123.5%) | $154.07 M(-44.6%) |
| Dec 2019 | $278.14 M(+1.6%) | $168.41 M(+543.7%) | $278.14 M(-35.3%) |
| Sept 2019 | - | $26.16 M(-3086.6%) | $429.81 M(+7.7%) |
| June 2019 | - | -$876.00 K(-101.0%) | $399.08 M(+11.0%) |
| Mar 2019 | - | $84.44 M(-73.6%) | $359.61 M(+31.4%) |
| Dec 2018 | $273.74 M(>+9900.0%) | $320.08 M(-7120.8%) | $273.74 M(-655.8%) |
| Sept 2018 | - | -$4.56 M(-88.7%) | -$49.25 M(+4.1%) |
| June 2018 | - | -$40.35 M(+2741.9%) | -$47.31 M(+371.4%) |
| Mar 2018 | - | -$1.42 M(-51.4%) | -$10.04 M(-2983.9%) |
| Dec 2017 | $346.00 K(-100.6%) | -$2.92 M(+11.8%) | $348.00 K(-99.4%) |
| Sept 2017 | - | -$2.61 M(-15.4%) | $55.29 M(-15.3%) |
| June 2017 | - | -$3.08 M(-134.4%) | $65.25 M(+468.3%) |
| Mar 2017 | - | $8.96 M(-82.8%) | $11.48 M(-119.0%) |
| Dec 2016 | -$60.40 M(-31.6%) | $52.02 M(+607.7%) | -$60.40 M(-67.1%) |
| Sept 2016 | - | $7.35 M(-112.9%) | -$183.85 M(-19.0%) |
| June 2016 | - | -$56.85 M(-9.6%) | -$226.98 M(+68.8%) |
| Mar 2016 | - | -$62.92 M(-11.9%) | -$134.48 M(+52.3%) |
| Dec 2015 | -$88.28 M(+126.4%) | -$71.43 M(+99.7%) | -$88.28 M(-721.3%) |
| Sept 2015 | - | -$35.78 M(-200.4%) | $14.21 M(-39.0%) |
| June 2015 | - | $35.65 M(-313.2%) | $23.31 M(-195.4%) |
| Mar 2015 | - | -$16.72 M(-153.8%) | -$24.42 M(-37.4%) |
| Dec 2014 | -$38.98 M(-35.7%) | $31.05 M(-216.4%) | -$38.98 M(-58.7%) |
| Sept 2014 | - | -$26.68 M(+120.8%) | -$94.31 M(+2.3%) |
| June 2014 | - | -$12.08 M(-61.4%) | -$92.21 M(+2.2%) |
| Mar 2014 | - | -$31.28 M(+28.9%) | -$90.25 M(+48.8%) |
| Dec 2013 | -$60.64 M(-7.4%) | -$24.28 M(-1.2%) | -$60.64 M(+55.5%) |
| Sept 2013 | - | -$24.57 M(+142.6%) | -$39.01 M(-25.1%) |
| June 2013 | - | -$10.13 M(+505.6%) | -$52.07 M(+20.7%) |
| Mar 2013 | - | -$1.67 M(-36.6%) | -$43.16 M(-34.1%) |
| Dec 2012 | -$65.48 M(-22.8%) | -$2.64 M(-93.0%) | -$65.48 M(-21.0%) |
| Sept 2012 | - | -$37.64 M(+3018.4%) | -$82.88 M(+14.9%) |
| June 2012 | - | -$1.21 M(-95.0%) | -$72.12 M(-18.8%) |
| Mar 2012 | - | -$24.00 M(+19.8%) | -$88.80 M(+4.7%) |
| Dec 2011 | -$84.80 M(+38.4%) | -$20.04 M(-25.5%) | -$84.80 M(+7.7%) |
| Sept 2011 | - | -$26.88 M(+50.3%) | -$78.75 M(+22.4%) |
| June 2011 | - | -$17.89 M(-10.5%) | -$64.32 M(-10.1%) |
| Mar 2011 | - | -$19.99 M(+43.0%) | -$71.59 M(+16.9%) |
| Dec 2010 | -$61.25 M(-139.5%) | -$13.99 M(+12.3%) | -$61.25 M(-4.5%) |
| Sept 2010 | - | -$12.45 M(-50.5%) | -$64.11 M(+1.4%) |
| June 2010 | - | -$25.15 M(+160.4%) | -$63.23 M(+54.9%) |
| Mar 2010 | - | -$9.66 M(-42.6%) | -$40.81 M(-126.3%) |
| Dec 2009 | $155.07 M(-953.3%) | -$16.84 M(+45.4%) | $155.07 M(-4.1%) |
| Sept 2009 | - | -$11.58 M(+324.2%) | $161.64 M(-7.5%) |
| June 2009 | - | -$2.73 M(-101.5%) | $174.84 M(+0.6%) |
| Mar 2009 | - | $186.22 M(-1914.6%) | $173.83 M(-1056.6%) |
| Dec 2008 | -$18.17 M(+65.3%) | -$10.26 M(-736.2%) | -$18.17 M(+22.2%) |
| Sept 2008 | - | $1.61 M(-143.2%) | -$14.87 M(-521.5%) |
| June 2008 | - | -$3.74 M(-35.4%) | $3.53 M(-193.8%) |
| Mar 2008 | - | -$5.79 M(-16.8%) | -$3.76 M(-65.8%) |
| Dec 2007 | -$10.99 M | -$6.96 M(-134.8%) | -$10.99 M(-39.5%) |
| Sept 2007 | - | $20.01 M(-281.5%) | -$18.18 M(-63.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2007 | - | -$11.02 M(-15.3%) | -$50.30 M(+21.4%) |
| Mar 2007 | - | -$13.02 M(-8.0%) | -$41.44 M(-9.7%) |
| Dec 2006 | -$45.90 M(-36.6%) | -$14.15 M(+16.9%) | -$45.90 M(+15.7%) |
| Sept 2006 | - | -$12.11 M(+457.3%) | -$39.67 M(-7.2%) |
| June 2006 | - | -$2.17 M(-87.6%) | -$42.74 M(-29.0%) |
| Mar 2006 | - | -$17.48 M(+120.9%) | -$60.22 M(-16.8%) |
| Dec 2005 | -$72.40 M(-49.2%) | -$7.91 M(-47.8%) | -$72.40 M(-40.7%) |
| Sept 2005 | - | -$15.17 M(-22.8%) | -$122.03 M(-12.6%) |
| June 2005 | - | -$19.66 M(-33.7%) | -$139.56 M(-4.3%) |
| Mar 2005 | - | -$29.66 M(-48.5%) | -$145.85 M(+2.4%) |
| Dec 2004 | -$142.50 M(+50.0%) | -$57.54 M(+75.9%) | -$142.50 M(+29.2%) |
| Sept 2004 | - | -$32.71 M(+26.0%) | -$110.34 M(+10.5%) |
| June 2004 | - | -$25.95 M(-1.4%) | -$99.83 M(+2.9%) |
| Mar 2004 | - | -$26.31 M(+3.7%) | -$96.98 M(+2.1%) |
| Dec 2003 | -$95.00 M(+31.5%) | -$25.38 M(+14.3%) | -$95.00 M(+11.2%) |
| Sept 2003 | - | -$22.20 M(-3.9%) | -$85.45 M(+5.7%) |
| June 2003 | - | -$23.10 M(-5.0%) | -$80.83 M(+2.8%) |
| Mar 2003 | - | -$24.32 M(+53.7%) | -$78.59 M(+8.8%) |
| Dec 2002 | -$72.24 M(-2.2%) | -$15.83 M(-9.9%) | -$72.24 M(+0.3%) |
| Sept 2002 | - | -$17.58 M(-15.8%) | -$72.04 M(+7.9%) |
| June 2002 | - | -$20.86 M(+16.1%) | -$66.78 M(-3.2%) |
| Mar 2002 | - | -$17.97 M(+15.0%) | -$68.96 M(-6.6%) |
| Dec 2001 | -$73.83 M(+38.0%) | -$15.63 M(+26.9%) | -$73.83 M(+0.2%) |
| Sept 2001 | - | -$12.32 M(-46.5%) | -$73.65 M(+10.3%) |
| June 2001 | - | -$23.04 M(+0.9%) | -$66.75 M(+15.1%) |
| Mar 2001 | - | -$22.85 M(+47.9%) | -$58.01 M(+8.5%) |
| Dec 2000 | -$53.48 M(-9.7%) | -$15.45 M(+185.6%) | -$53.48 M(-3.9%) |
| Sept 2000 | - | -$5.41 M(-62.2%) | -$55.64 M(-11.2%) |
| June 2000 | - | -$14.30 M(-22.0%) | -$62.63 M(-3.4%) |
| Mar 2000 | - | -$18.33 M(+4.1%) | -$64.83 M(+9.7%) |
| Dec 1999 | -$59.20 M(+37.7%) | -$17.60 M(+41.9%) | -$59.10 M(+1.5%) |
| Sept 1999 | - | -$12.40 M(-24.8%) | -$58.20 M(+24.4%) |
| June 1999 | - | -$16.50 M(+31.0%) | -$46.80 M(+6.1%) |
| Mar 1999 | - | -$12.60 M(-24.6%) | -$44.10 M(+2.6%) |
| Dec 1998 | -$43.00 M(+38.3%) | -$16.70 M(+1570.0%) | -$43.00 M(+15.6%) |
| Sept 1998 | - | -$1.00 M(-92.8%) | -$37.20 M(-3.1%) |
| June 1998 | - | -$13.80 M(+20.0%) | -$38.40 M(+12.9%) |
| Mar 1998 | - | -$11.50 M(+5.5%) | -$34.00 M(+9.3%) |
| Dec 1997 | -$31.10 M(+17.4%) | -$10.90 M(+395.5%) | -$31.10 M(+9.9%) |
| Sept 1997 | - | -$2.20 M(-76.6%) | -$28.30 M(-11.8%) |
| June 1997 | - | -$9.40 M(+9.3%) | -$32.10 M(+7.0%) |
| Mar 1997 | - | -$8.60 M(+6.2%) | -$30.00 M(+13.2%) |
| Dec 1996 | -$26.50 M(+11.8%) | -$8.10 M(+35.0%) | -$26.50 M(+12.8%) |
| Sept 1996 | - | -$6.00 M(-17.8%) | -$23.50 M(-3.7%) |
| June 1996 | - | -$7.30 M(+43.1%) | -$24.40 M(+6.1%) |
| Mar 1996 | - | -$5.10 M(0.0%) | -$23.00 M(-3.4%) |
| Dec 1995 | -$23.70 M(+30.2%) | -$5.10 M(-26.1%) | -$23.80 M(-3.6%) |
| Sept 1995 | - | -$6.90 M(+16.9%) | -$24.70 M(+6.5%) |
| June 1995 | - | -$5.90 M(0.0%) | -$23.20 M(+3.6%) |
| Mar 1995 | - | -$5.90 M(-1.7%) | -$22.40 M(+23.1%) |
| Dec 1994 | -$18.20 M(-4.7%) | -$6.00 M(+11.1%) | -$18.20 M(+8.3%) |
| Sept 1994 | - | -$5.40 M(+5.9%) | -$16.80 M(+5.0%) |
| June 1994 | - | -$5.10 M(+200.0%) | -$16.00 M(+1.9%) |
| Mar 1994 | - | -$1.70 M(-63.0%) | -$15.70 M(-17.8%) |
| Dec 1993 | -$19.10 M(-2.1%) | -$4.60 M(0.0%) | -$19.10 M(-3.5%) |
| Sept 1993 | - | -$4.60 M(-4.2%) | -$19.80 M(-1.5%) |
| June 1993 | - | -$4.80 M(-5.9%) | -$20.10 M(+2.6%) |
| Mar 1993 | - | -$5.10 M(-3.8%) | -$19.60 M(+0.5%) |
| Dec 1992 | -$19.50 M(+124.1%) | -$5.30 M(+8.2%) | -$19.50 M(+12.1%) |
| Sept 1992 | - | -$4.90 M(+14.0%) | -$17.40 M(+16.8%) |
| June 1992 | - | -$4.30 M(-14.0%) | -$14.90 M(+18.3%) |
| Mar 1992 | - | -$5.00 M(+56.3%) | -$12.60 M(+44.8%) |
| Dec 1991 | -$8.70 M(+93.3%) | -$3.20 M(+33.3%) | -$8.70 M(+31.8%) |
| Sept 1991 | - | -$2.40 M(+20.0%) | -$6.60 M(+24.5%) |
| June 1991 | - | -$2.00 M(+81.8%) | -$5.30 M(+20.5%) |
| Mar 1991 | - | -$1.10 M(0.0%) | -$4.40 M(0.0%) |
| Dec 1990 | -$4.50 M | -$1.10 M(0.0%) | -$4.40 M(+33.3%) |
| Sept 1990 | - | -$1.10 M(0.0%) | -$3.30 M(+50.0%) |
| June 1990 | - | -$1.10 M(0.0%) | -$2.20 M(+100.0%) |
| Mar 1990 | - | -$1.10 M | -$1.10 M |
FAQ
- What is Ionis Pharmaceuticals annual net profit?
- What is the all time high annual net income for Ionis Pharmaceuticals?
- What is Ionis Pharmaceuticals annual net income year-on-year change?
- What is Ionis Pharmaceuticals quarterly net profit?
- What is the all time high quarterly net income for Ionis Pharmaceuticals?
- What is Ionis Pharmaceuticals quarterly net income year-on-year change?
- What is Ionis Pharmaceuticals TTM net profit?
- What is the all time high TTM net income for Ionis Pharmaceuticals?
- What is Ionis Pharmaceuticals TTM net income year-on-year change?
What is Ionis Pharmaceuticals annual net profit?
The current annual net income of IONS is -$366.29 M
What is the all time high annual net income for Ionis Pharmaceuticals?
Ionis Pharmaceuticals all-time high annual net profit is $278.14 M
What is Ionis Pharmaceuticals annual net income year-on-year change?
Over the past year, IONS annual net profit has changed by -$96.56 M (-35.80%)
What is Ionis Pharmaceuticals quarterly net profit?
The current quarterly net income of IONS is -$140.48 M
What is the all time high quarterly net income for Ionis Pharmaceuticals?
Ionis Pharmaceuticals all-time high quarterly net profit is $320.08 M
What is Ionis Pharmaceuticals quarterly net income year-on-year change?
Over the past year, IONS quarterly net profit has changed by +$6.93 M (+4.70%)
What is Ionis Pharmaceuticals TTM net profit?
The current TTM net income of IONS is -$358.81 M
What is the all time high TTM net income for Ionis Pharmaceuticals?
Ionis Pharmaceuticals all-time high TTM net profit is $429.81 M
What is Ionis Pharmaceuticals TTM net income year-on-year change?
Over the past year, IONS TTM net profit has changed by +$50.64 M (+12.37%)